http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03028716-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c0dd2546ac43083142146cb4850b8b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd41343dd98f8c585483d3845a2d0bb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba872f5ea7219e78c11a9d11c6b5e970
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6831b19bfc354357342f7c7da79fc162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
filingDate 2002-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d650b3745d15c636e5bcf24a8182aed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_490618c28224a6e78a0aae78f08a06ea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c228daad616f704e593308f8e749c8
publicationDate 2003-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-03028716-A1
titleOfInvention Aqueous ecabet sodium solution preparation
abstract An aqueous ecabet sodium solution preparation which contains sulfodehydroabietic acid and a salt/ion thereof in an amount of 1 w/v% or larger in terms of ecabet sodium and further contains at least one pH buffer selected among polycarboxylic acid salts and polyphosphoric acid salts and an inorganic base so as to have a pH regulated to 7 to 8.5. It is stable and less irritative and is suitable for use in intestinal injections.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8043662-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009221199-A
priorityDate 2001-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H09136832-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87106789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226760304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134403001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID230169496
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18598684

Total number of triples: 37.